SUSTINEM NOILE TERAPII PENTRU ERADICAREA VIRUSULUI HEPATIC C

Virgil

/ #91

2015-02-19 15:45

According to Portuguese daily newspaper Publico, the agreement between the Ministry of Health, the National Authority for Medication and U.S. drug industry group Gilead Sciences was made on Thursday night, following a week of intense negotiations.

Sovaldi, which has a cure rate of 90 percent, is expected to cost up to 25,000 euros (28,287 U.S. dollars) in Portugal per treatment, the same price agreed for Spain.

Gilead Sciences has faced controversy regarding the price of its drug. However, the U.S. company has maintained that it is a priceless breakthrough for both patients and their families.